Formycon Delay Pushes Back Coherus’ Ranibizumab

FDA Requests Additional Data On Lucentis Rival

 
• By David Wallace
  
Delayed
Formycon and Bioeq's US Ranibizumab Application Has Been Delayed • Source: Shutterstock

More from Biosimilars

More from Products